Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran

Ann Clin Microbiol Antimicrob. 2021 Nov 3;20(1):76. doi: 10.1186/s12941-021-00482-3.

Abstract

Background: The emergence of carbapenem-resistant Pseudomonas aeruginosa is one of the most important challenges in a healthcare setting. The aim of this study is double-locus sequence typing (DLST) typing of blaNDM-1 positive P. aeruginosa isolates.

Methods: Twenty-nine blaNDM-1 positive isolates were collected during three years of study from different cities in Iran. Modified hodge test (MHT), double-disk synergy test (DDST) and double-disk potentiation test (DDPT) was performed for detection of carbapenemase and metallo-beta-lactamase (MBL) producing blaNDM-1 positive P. aeruginosa isolates. The antibiotic resistance genes were considered by PCR method. Clonal relationship of blaNDM-1 positive was also characterized using DLST method.

Results: Antibiotic susceptibility pattern showed that all isolates were resistant to imipenem and ertapenem. DDST and DDPT revealed that 15/29 (51.8%) and 26 (89.7%) of blaNDM-1 positive isolates were MBL producing isolates, respectively. The presence of blaOXA-10, blaVIM-2, blaIMP-1 and blaSPM genes were detected in 86.2%, 41.4%, 34.5% and 3.5% isolates, respectively. DLST typing results revealed the main cluster were DLST 25-11 with 13 infected or colonized patients.

Conclusions: The presence of blaNDM-1 gene with other MBLs encoding genes in P. aeruginosa is a potential challenge in the treatment of microorganism infections. DLST showed partial diversity among 29 blaNDM-1 positive isolates.

Keywords: DLST; MBL; MHT; Pseudomonas aeruginosa; bla NDM-1.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cross Infection / microbiology*
  • Drug Resistance, Multiple, Bacterial
  • Ertapenem / pharmacology
  • Humans
  • Imipenem / pharmacology
  • Inpatients
  • Iran / epidemiology
  • Microbial Sensitivity Tests
  • Molecular Typing
  • Polymerase Chain Reaction
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / genetics*
  • Pseudomonas aeruginosa / isolation & purification
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Imipenem
  • beta-Lactamases
  • beta-lactamase NDM-1
  • Ertapenem